Stéphanie Kermorgant

Stéphanie Kermorgant is a Professor of Cellular Oncology and Group Leader at the Centre for Tumour Biology. Her research focuses on the role of growth factor receptor signaling and intracellular trafficking in tumor growth and metastasis, aiming to improve cancer therapies.

• Institution: Centre for Tumour Biology
• Academic Rank: Professor

Research Interests: Stéphanie's work centers on understanding how receptor tyrosine kinases like c-Met and their intracellular trafficking mechanisms influence tumor progression and metastatic behavior. She investigates signaling pathways from autophagy-related endomembranes, integrin cooperation, and cytoskeletal regulation.

Publications Overview: Her key publications highlight mechanisms linking MET signaling to autophagy, integrin-MET interactions, and cytoskeletal dynamics in cancer cells. These studies emphasize the role of endomembrane compartments in oncogenic processes across breast, lung, ovarian, and pancreatic cancers.

• Major Funding:
  • Medical Research Council Project Grant (2018–2021): £502,856.32
  • OCTIMET Oncology Grant (2018–2019): £327,480

Academic Service: She serves on the Norwegian Cancer Society Grants External Review Panel, the London Interdisciplinary Biosciences Consortium (LIDo) Management Committee, and as an Academic Editor for Cells and Reviewer Editor for Frontiers in Molecular Bioscience and Frontiers Oncology.